Kenyan researchers work to produce East Africa's first antivenom

Kenyan mother Beth Mwende heard her sleeping three-year-old cry out, but did not worry further after the child quickly settled - until the next morning, when she found her daughter, Mercy, semi-conscious with two fang marks in the neck.

China's New Hope breaks into Southeast Asia pig farming amid disease woes

In a cluster of blue and white buildings nestled deep inside one of southern Vietnam's rubber plantations, China's New Hope Liuhe is busy stocking its first overseas pig farm with young sows.

Morphosys shares fall after dermatitis treatment flops

German biotech company Morphosys halted development of an experimental atopic dermatitis treatment that analysts had pinned hopes of blockbuster sales potential on, sending its shares down as much as 6.8% on Tuesday.

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Johnson & Johnson received grand jury subpoenas in August from the U.S. attorney's office for the Eastern District of New York related to its opioid medication policies, the company said in a regulatory filing on Monday.

Missouri, Planned Parenthood debate 'safety concerns' at abortion clinic hearing

The fate of Missouri's only abortion clinic was at stake on Monday, as a state arbiter heard arguments from Planned Parenthood and state officials who have threatened to close it and make Missouri the sole U.S. state without legal abortion services.

Allergan settles Alzheimer's therapy lawsuit for $750 million

Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer's disease therapy Namenda, the drugmaker said, in a resolution to the litigation that was set to face trial on Monday.

Medicinal cannabis not proven in mental health, study finds

Evidence is weak for whether medicinal cannabis treatments can relieve mental illnesses such as anxiety, depression and psychosis, and doctors should prescribe them with great caution, researchers said on Monday.

People taking blood thinners may risk danger by mixing with OTC meds

(Reuters Health) - People taking blood-thinning medications often use over-the-counter (OTC) medicines with the potential to cause dangerous internal bleeding, a recent study suggests.

Mirati drug shrinks tumors in some cancer patients in early-stage trial

An experimental drug from Mirati Therapeutics Inc that targets a specific genetic mutation significantly reduced tumor size in 40% of patients with advanced lung and colorectal cancer so far evaluated in a small, early-stage trial, researchers said on Monday.

Female and minority health professionals face discrimination from rural colleagues

(Reuters Health) - Even as rural America struggles to attract enough healthcare providers, women and minority health professionals are sometimes driven out of rural communities by the discrimination and harassment from colleagues, a new study finds.

With more choices of vegetarian cafeteria meals, more are sold

(Reuters Health) - When cafeterias sell more vegetarian meals, people will indeed purchase more meat-free entrees, a recent study suggests.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS